Skip to content
PIL Logo

Setofilm 4 & 8 mg Orodispersible Films

Last Updated on eMC 17-Jan-2017 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17-Jan-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - overdose, missed or forgotten doses

Updated on 21-Nov-2016 and displayed until 17-Jan-2017

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 05-Jan-2016 and displayed until 21-Nov-2016

Reasons for adding or updating:

  • Change to section 6 - date of revision

Updated on 30-Jan-2014 and displayed until 05-Jan-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 03-Jun-2013 and displayed until 30-Jan-2014

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

ondansetron

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue